To ask Her Majesty’s Government what research is currently being funded by the National Institute for Health Research for the treatment of systemic amyloidosis or multiple myeloma.

The National Institute for Health Research (NIHR) Clinical Research Network is currently setting up a study that will aim to image amyloid deposition in systemic amyloidosis using hybrid positron emission tomography/magnetic resonance imaging, with the future potential to diagnose and monitor treatment response in this condition.

The NIHR Health Technology Assessment programme is funding a £1.9 million trial assessing the benefit of antibiotic prophylaxis and its effect on healthcare associated infections in myeloma patients.

The NIHR is hosting a wide range of commercial and non-commercial myeloma treatment trials and studies through its Clinical Research Network, biomedical research centres, clinical research facilities, and through experimental cancer medicine centres funded jointly with Cancer Research UK.